Daewoong Pharma Net Asset Quality Index
Daewoong Pharma net asset quality index. Daewoong Pharma (069620) has a Net Asset Quality Index of 44.4% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩2.26 Trillion minus total liabilities of ₩1.26 Trillion yields net assets of ₩1.00 Trillion. A higher index indicates a stronger, lower-leverage balance sheet. Check Daewoong Pharma (069620) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Daewoong Pharma (2007–2024)
Net asset quality index of Daewoong Pharma from 2007 to 2024. This chart shows how Daewoong Pharma's Net Asset Quality Index has evolved across 16 annual periods from 2007 to 2024. As of September 2025, the index stands at 44.4%, representing net assets of ₩1.00 Trillion against total assets of ₩2.26 Trillion KRW. See 069620 net asset value for net asset value and shareholders' equity analysis.
Daewoong Pharma Net Asset Quality Index by Year (2007–2024)
Daewoong Pharma net asset quality index by year from 2007 to 2024. The table below presents the year-by-year Net Asset Quality Index for Daewoong Pharma from 2007 to 2024, covering 16 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 069620 market cap.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 46.9% | ₩926.98 Billion | ₩1.98 Trillion | ₩1.05 Trillion | ▼ -4.4 pp |
| 2023 | 51.3% | ₩802.97 Billion | ₩1.57 Trillion | ₩762.77 Billion | ▲ +3.9 pp |
| 2022 | 47.4% | ₩741.22 Billion | ₩1.56 Trillion | ₩822.12 Billion | ▼ -2.2 pp |
| 2021 | 49.6% | ₩702.41 Billion | ₩1.42 Trillion | ₩712.77 Billion | ▼ -1.2 pp |
| 2020 | 50.9% | ₩695.25 Billion | ₩1.37 Trillion | ₩671.66 Billion | ▼ -0.2 pp |
| 2019 | 51.1% | ₩635.92 Billion | ₩1.25 Trillion | ₩609.75 Billion | ▲ +0.7 pp |
| 2018 | 50.3% | ₩607.81 Billion | ₩1.21 Trillion | ₩600.04 Billion | ▼ -1.7 pp |
| 2017 | 52.0% | ₩631.54 Billion | ₩1.21 Trillion | ₩581.99 Billion | ▼ -0.8 pp |
| 2016 | 52.8% | ₩604.55 Billion | ₩1.14 Trillion | ₩540.15 Billion | ▼ -8.6 pp |
| 2015 | 61.4% | ₩580.24 Billion | ₩944.53 Billion | ₩364.29 Billion | ▼ -4.2 pp |
| 2014 | 65.6% | ₩455.51 Billion | ₩694.26 Billion | ₩238.76 Billion | ▼ -10.0 pp |
| 2013 | 75.6% | ₩437.96 Billion | ₩579.01 Billion | ₩141.05 Billion | ▼ -4.5 pp |
| 2012 | 80.1% | ₩386.59 Billion | ₩482.34 Billion | ₩95.76 Billion | ▲ +7.4 pp |
| 2011 | 72.7% | ₩362.42 Billion | ₩498.46 Billion | ₩136.04 Billion | ▲ +15.4 pp |
| 2008 | 57.3% | ₩278.85 Billion | ₩486.24 Billion | ₩207.39 Billion | ▼ -11.3 pp |
| 2007 | 68.6% | ₩269.57 Billion | ₩392.81 Billion | ₩123.24 Billion | — |